Approval · Notice of Compliance 15515 · 2014
ORCIPRENALINE: Notice of Compliance 15515
Issued April 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15515
- Date
- April 17, 2014
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Beta2-adrenergic stimulant; bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORCIPRENALINE | 02236783 | Dormant |
Medicinal ingredients
- ORCIPRENALINE SULFATE 2 MG per ML